ANDRE RIVERO GUEVARA: Open Payments
NPI 1588622476 · HOMESTEAD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 34 payments from 7 companies in 2025. Trend: 2023 $698 · 2024 $1,305 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 17 | $272 |
| Axsome Therapeutics, Inc. | 8 | $152 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Tris Pharma Inc | 1 | $23 |
Products named: Qelbree, Auvelity, INVEGA SUSTENNA, COBENFY, AUSTEDO XR, CAPLYTA, Dyanavel XR.
Industry payments across FL — which companies pay providers there.
